Oxford Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
+3,598
| New | +$1.03M | 0.37% | 50 |
|
|
2020
Q1 | – | Sell |
-23,088
| Closed | -$2.03M | – | 1254 |
|
|
2019
Q4 | $2.03M | Sell |
23,088
-2,890
| -11% | -$255K | 0.06% | 408 |
|
|
2019
Q3 | $2.07M | Buy |
25,978
+10,911
| +72% | +$870K | 0.05% | 515 |
|
|
2019
Q2 | $1.18M | Buy |
+15,067
| New | +$1.18M | 0.03% | 892 |
|
|
2017
Q3 | – | Sell |
-29,032
| Closed | -$3.77M | – | 1717 |
|
|
2017
Q2 | $3.77M | Buy |
29,032
+16,682
| +135% | +$2.16M | 0.08% | 280 |
|
|
2017
Q1 | $1.67M | Sell |
12,350
-714
| -5% | -$96.7K | 0.04% | 574 |
|
|
2016
Q4 | $1.87M | Sell |
13,064
-152,647
| -92% | -$21.9M | 0.07% | 341 |
|
|
2016
Q3 | $19.6M | Buy |
165,711
+11,435
| +7% | +$1.35M | 0.6% | 31 |
|
|
2016
Q2 | $16.3M | Buy |
154,276
+59,246
| +62% | +$6.28M | 0.54% | 31 |
|
|
2016
Q1 | $10.6M | Sell |
95,030
-6,824
| -7% | -$760K | 0.3% | 62 |
|
|
2015
Q4 | $16.1M | Buy |
101,854
+4,569
| +5% | +$724K | 0.38% | 39 |
|
|
2015
Q3 | $12.8M | Sell |
97,285
-1,661
| -2% | -$218K | 0.4% | 40 |
|
|
2015
Q2 | $17.2M | Sell |
98,946
-8,340
| -8% | -$1.45M | 0.47% | 27 |
|
|
2015
Q1 | $18.5M | Buy |
107,286
+3,074
| +3% | +$530K | 0.47% | 31 |
|
|
2014
Q4 | $13.5M | Sell |
104,212
-4,370
| -4% | -$566K | 0.3% | 53 |
|
|
2014
Q3 | $14M | Buy |
108,582
+75,674
| +230% | +$9.77M | 0.32% | 53 |
|
|
2014
Q2 | $2.91M | Buy |
+32,908
| New | +$2.91M | 0.09% | 304 |
|
|
2014
Q1 | – | Sell |
-189,533
| Closed | -$21.4M | – | 777 |
|
|
2013
Q4 | $21.4M | Buy |
+189,533
| New | +$21.4M | 0.54% | 22 |
|
|
2013
Q3 | – | Sell |
-9,666
| Closed | -$636K | – | 904 |
|
|
2013
Q2 | $636K | Buy |
+9,666
| New | +$636K | 0.02% | 662 |
|